Transfusion transmitted infections in thalassaemics: Need for reappraisal of blood screening strategy in india

Transfusion Medicine

Volumn 24, Issue 2, 2014, Pages 79-88

  Shyamala, V ^a  

^a Research Diagnostics Inc   (India)

Author keywords

Nucleic acid technology testing; Occult infections; Repeat recipients; Serology markers; thalassaemics; Transfusion transmitted viral infections in India; Window period

Indexed keywords

ARTICLE; BETA THALASSEMIA; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAFETY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INDIA; NUCLEIC ACID ANALYSIS; PREVALENCE; SEROLOGY; THALASSEMIA; TRANSFUSION TRANSMITTED INFECTION; VIRUS TRANSMISSION; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; DONOR SELECTION; TRANSMISSION; VIROLOGY; VIRUS DISEASES;

BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DONOR SELECTION; HUMANS; INDIA; THALASSEMIA; VIRUS DISEASES;

EID: 84897107918     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12110     Document Type: Article

References (60)

1. Abraham, P. (2012) Viral hepatitis in India. Clinical Laboratory Medicine, 32, 159-174.
2. Agarwal, N., Chatterjee, K., Coshic, P. & Borgohain, M. (2013) Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India. Transfusion and Apheresis Science, 49, 482-484.
3. Allain, J.P., Mihaljevic, I., Gonzalez-Fraile, M.I. et al. (2013) Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion, 53, 1405-1415.
4. Azarkeivan, A., Toosi, M.N., Maghsudlu, M., Kaiabad, S.A., Hajibeigi, B. & Hadizadeh, M. (2012) The incidence of hepatitis C in patients with thalassemia after screening in blood transfusion centers: a fourteen-year study. Transfusion, 52, 1814-1818.
5. Center for Disease Control and Prevention (CDC) (2013) Detection of acute HIV infection in two evaluations of a new HIV diagnostic testing algorithm- United States, 2011-2013. MMWR, 62, 489-494.
6. Chatterjee, K. (2012) An improved NAT assay with enhanced sensitivity for HBV for donor blood screening. Journal of Laboratory Physicians, 4, 127.
7. Choudhury, N. (2011) Need to change present regulatory framework for blood banks in India. Asian Journal of Transfusion Science, 5, 1-2.
8. Choudhury, N.C., Saraswat, S. & Naveed, M. (1998) Serological monitoring of thalassemia major patients for transfusion associated viral infections. Indian Journal of Medical Research, 107, 263-268.
9. Di Marco, V., Capra, M., Angelucci, E. et al. & on behalf of the Italian Society for the study of thalassemia and haemoglobinopathies and Italian association for the study of the liver (2010) Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood, 116, 2875-2883.
10. Duraiswamy, G., Zuridah, H. & Ariffin, M.Y. (1993) Prevalence of hepatitis C virus antibodies in blood donors in Malaysia. Medical Journal of Malaysia, 48, 313-316.
11. El-Faramawy, A.A.M., El-Rashidy, O.F., Tawfik, P.H. & Hussein, G.H. (2012) Transfusion transmitted hepatitis: where do we stand now? A one center study in Upper Egypt. Hepatitis Monthly, 12, 286-291.
12. El-Shanshory, M.R., Kabbash, I.A., Saliman, H.H., Nagy, H.M. & Abdou, S.H. (2013) Prevalence of hepatitis C infection among children with β-thalassemia major in Mid delta, Egypt: a single center study. Transactions of the Royal Society Tropical Medicine Hygiene, 107, 224-228.
13. Gerlich, W.H., Glebe, D. & Schuttler, C.G. (2007) Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. Journal of Viral Hepatology, 14 (Suppl. 1), 16-21.
14. Ghosh, S., Banerjee, P., Deny, P. et al. (2013) New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India. Journal of Viral Hepatitis, 20, 209-218.
15. Haslina, M.N.N., Khairiah, Y., Zakuan Zainy, D., Shafini, M.Y., Rosnah, B. & Marini, R. (2012) Seroprevalence of hepatits C virus infection among blood donors in a teaching hospital in northeastern Malaysia. Southeast Asian journal of Tropical Medicine and Public Health, 43, 668-673.
16. van, Hulst, M., Hubben, G.A.A., Sagoe, K.W.C. et al. (2009) Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. Transfusion, 49, 2729-2742.
17. Jain, R., Perkins, J., Johnson, S.T., Desai, P., Khatri, A., Chudgar, U. & Choudhury, N. (2012) A prospective study for prevalence and/or development of transfusion-transmitted Infections in multiply transfused thalassemia major patients. Asian Journal of Transfusion Science, 6, 151-154.
18. Jaiswal, S.P.B., Chitnis, D.S., Jain, A.K., Inamdar, S., Porwal, A. & Jain, S.C. (2001) Prevalence of hepatitis viruses among multi-transfused homogenous thalassemia patients. Hepatology Research, 19, 247-253.
19. Kaur, R., Basu, S., Kaur, G. & Singh, D. (2011) Fourth generation enzyme immunoassays for screening of HIV in blood donors: need of the hour. Indian Journal of Pathology and Microbiology, 54, 433-434.
20. Khakhkhar, V. & Joshi, P.J. (2006) HBsAg seropositivity among multi-transfused thalassemic children. Indian Journal of Pathology and Microbiology, 49, 516-518.
21. Kleinman, S.H., Lelie, N. & Busch, M.P. (2009) Infectivity of human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and risk of transmission by transfusion. Transfusion, 49, 2454-2489.
22. Kumar, R. & Kaur, A. (2013) Importance of blood screening by nucleic acid testing with a repeat testing algorithm in hepatitis C and B virus high-prevalence region. Vox Sanguinis, 105 (Suppl. 2), 86.
23. Laperche, S. & on behalf of the Francophone African group for Research in Blood transfusion (2013) Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion, 53, 816-826.
24. Laperche, S., Le Marrec, N., Girault, A. et al. (2005) Simultaneous detection of Hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. Journal of Clinical Microbiology, 43, 3877-3883.
25. Lee, W.S., Teh, C.M. & Chan, L.L. (2005) Risks of seroconversion of hepatitis B, hepatitis C and human immunodeficiency viruses in children with multitransfused thalassemia major. Journal of Paediatrics Child Health, 41, 265-268.
26. Makroo, R.N., Choudhury, N., Jagannathan, L. et al. (2008) Multicenter evaluation of individual donor nucleic acid testing [NAT] for simultaneous detection of human immunodeficiency virus-1 and hepatitis B & C viruses in India blood donors. Indian Journal of Medical Research, 127, 140-147.
27. Makroo, R.N., Chowdhry, M., Bhatia, A., Arora, B. & Rosamma, N.L. (2011) Prevalence of HIV among blood donors in a tertiary care centre of North India. Indian Journal of Medical Research, 134, 950-953.
28. Makroo, R.N., Chowdhry, M., Bhatia, A., Arora, B. & Rosamma, N.L. (2012) Hepatitis B core antibody testing in Indian blood donors: a double-edged sword!. Asian Journal of Transfusion Science, 6, 10-13.
29. Malhotra, S., Marwaha, N. & Saluja, K. (2013) Seroprevalence of human immunodeficiency virus in North Indian blood donors using third and fourth generation enzyme linked immunosorbent assay. Asian Journal of Transfusion Science, 7, 125-129.
30. Marwaha, N. (2010) Whole blood and component use in resource poor settings. Biologicals, 38, 68-71.
31. Mathur, M., Wanjari, K. & Turbadkar, D. (2008) Surveillance of HIV, hepatitis C and hepatitis B in multitransfused thalassemics. Indian Journal of Medical Microbiology, 26, 205-206.
32. Mukhopadhya, A. (2008) Hepatitis C in India. Journal of Biosciences, 33, 465-473.
33. National Aids Control Organisation Ministry of Health and family Welfare (2007) Standards for Blood banks and Blood Transfusion Services. Government of India, New Delhi.
34. National Aids Control Organisaton, Department of AIDS Control, Ministry of Health & Family Welfare, Government of India. Computerised Management Information Systems (CMIS) bulletin (April 2008- March 2009) [WWW document]. URL http://aidsdatahub.org/en/india-reference-library/item/12112-annual-cmis-bulletin-2008-09-national-aids-control-organisation-india-2010 (Accessed 10/10/13)
35. Panigrahi, I. & Marwaha, R.K. (2007) Mutational spectrum of thalssemias in India. Indian Journal of Human Genetics, 31, 36-37.
36. Panigrahi, R., Biswas, A., Datta, S. et al. (2010) Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in Southeastern India: implications for transfusion. Virology Journal, 7, 204-210.
37. Raghuraman, S., Shaji, R.V., Sridharan, G., Radhakrishnan, S., Chandy, G., Ramakrishna, B.S. & Abraham, P. (2003a) Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in South India. Journal of Clinical Virology, 26, 61-69.
38. Raghuraman, S., Subramanian, T., Daniel, D., Sridharan, G. & Abraham, P. (2003b) Occurrence of false positives during testing for antibodies to Hepatitis C virus among volunteer blood donors in India. Journal of Clinical Microbiology, 41, 1788-1790.
39. Salles, N.A., Levi, J.E., Barreto, C.C., Sampaio, L.P., Romano, C.M., Sabino, E.C. & Mendrone, A. Jr. (2013) Human immunodeficiency virus transfusion transmission despite nucleic acid testing. Transfusion, 53, 2593-2595.
40. Sen, A. & Arora, S. (2012) Impact of individual donor nucleic-acid amplification testing of blood donors in interdicting transmission of transfusion transmitted HIV, hepatitis B and hepatitis C in India. Vox Sanguinis, 103 (Suppl. 1), 148-149.
41. Seth, P. (2010) Evolution of HIV-1 in India. Indian Journal of Virology, 21, 3-7.
42. Shah, N., Mishra, A., Chauhan, D., Vora, C. & Shah, N.R. (2010) Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion center in western India. Asian Journal of Transfusion Science, 4, 94-98.
43. Shrivastava, P. (2013) ID-NAT testing and the benefit of user algorithm in a stand-alone Indian blood bank. Vox Sanguinis, 105 (Suppl. 2), 83.
44. Shyamala, V. (2014) Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus. Asian Journal of Transfusion Science, 8, 13-18.
45. Sievert, W., Altraif, I., Razavi, H.A. et al. (2011) A systematic review of hepatitis C epidemiology in Asia, Australia and Egypt. Liver International, 32, 61-80.
46. Singh, H., Pradhan, M., Singh, R.L., Phadke, S., Naik, S.R., Aggarwal, R. & Naik, S. (2003) High frequency of hepatitis B virus infection in patients with β-thalassemia receiving multiple transfusions. Vox Sanguinis, 84, 292-299.
47. Sinha, S., Black, M.L., Agarwal, S., Das, R., Bittles, A.H. & Bellgard, M. (2011) ThalInd, a β- Thalassemia and hemoglobinopathies database for India: defining a model country-specific and disease-centric bioinformatics resource. Human Mutation, 32, 887-893.
48. Stramer, S.L., Wend, U., Candotti, D., Foster, G.A., Hollinger, F.B., Dodd, R.Y., Allain, J.-P. & Gerlich, W. (2011) Nucleic acid testing to detect HBV infection in blood donors. The New England Journal of Medicine, 364, 236-247.
49. Stramer, S.L., Dodd, R.Y. & Brodsky, J.P. (2013a) The value of screening signal-to-cutoff for Hepatitis C virus antibody confirmation. Transfusion, 53, 1497-1500.
50. Stramer, S.L., Notari, E.P., Krysztof, D.E. & Dodd, R.Y. (2013b) Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Transfusion, 53, 2449-2458.
51. Sudha, T., Teja, V.D., Gopal, M., Rajesh, M. & Lakshmi, V. (2005) Comparative evaluation of TRI-DOT rapid HIV test with fourth-generation ELISA for the detection of immunodeficiency virus. Clinical Microbiology and Infectious Diseases, 11, 834-855.
52. Thomas, D.L., Thio, C.L., Martin, M.P. et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature, 461, 798-802.
53. Toor, J.S., Shrama, A., Kumar, R., Gupta, P., Garg, P. & Arora, S.K. (2011) Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotype and docking analysis. Antiviral Research, 92, 213-218.
54. Tulsiani, S., Choudhury, N., Desai, P., Shah, R., Mathur, A., Harimoorthy, V. & Shah, J. (2012) True positivity of anti-hepatitis C virus enzyme-linked immunosorbent assay reactive blood donors: a prospective study done in western India. Asian Journal of Transfusion Science, 6, 165-168.
55. Verma, I.C., Saxena, R. & Kohli, S. (2011) Past, present & future scenario of thalassaemic care and control in India. Indian Journal of Medical Research, 134, 507-521.
56. Vermeulen, M., Dickens, C., Lelie, N. et al. (2012) Hepatitis B virus transmission by blood transmission during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion, 52, 880-892.
57. Vidja, P.K., Vachhani, J.H., Sheikh, S.S. & Santwani, P.M. (2011) Blood transfusion transmitted infections in multiple blood transfused patients of beta thalassemia. Indian Journal of Hematology and Blood Transfusion, 27, 65-69.
58. Waheed, Y., Shafi, T., Safi, S.Z. & Qadri, I. (2009) Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World Journal of Gastroenterology, 12, 5647-5653.
59. Weatherall, D.J. (2010) The inherited diseases of hemoglobin are an emerging global health burden. Blood, 115, 4331-4336.
60. WHO, WHO regional office for South East-Asia New Delhi (2002) Prevention of hepatitis B in India. SEA-Hepat.-5, SEA-EPI-141.